骨质疏松症管理中需区分干预阈值与诊断阈值
The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis.
PubMed 文献 · Osteoporos Int · 2022-10-25
国际骨质疏松基金会(IOF)与欧洲骨质疏松、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)的立场文件讨论了骨质疏松症中分别设立诊断阈值与干预阈值的理由。文件结论认为应保留当前基于骨密度(BMD)的骨质疏松症诊断标准,同时明确区分诊断阈值与干预阈值。
要点
- 应保留当前基于BMD的骨质疏松症诊断标准。
- 需明确区分诊断阈值与干预阈值。
- 该立场文件由IOF与ESCEO共同发布。
核心结论
- 应保留当前基于BMD的骨质疏松症诊断标准,同时明确区分诊断阈值与干预阈值。
研究设计与样本
- 国际骨质疏松基金会(IOF)与欧洲骨质疏松、骨关节炎和肌肉骨骼疾病临床与经济学会(ESCEO)的立场文件。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This position paper of the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) addresses the rationale for separate diagnostic and intervention thresholds in osteoporosis. We conclude that the current BMD-based diagnostic criteria for osteoporosis be retained whilst clarity is brought to bear on the distinction between diagnostic and intervention thresholds.
来源:Osteoporos Int,查看原文。版权归原作者所有。
引用
- Kanis JA, McCloskey EV, Harvey NC, et al. The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis. Osteoporos Int. 2022. PMID: 36282342. doi:10.1007/s00198-022-06567-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。